Shareholding disclosure

Martin und Rosmarie Ebner

Declared position

9.08%

Threshold

Crossed upwards

Timeline

Published

15.05.2013

Transaction

10.05.2013

Transfer date

10.05.2013

Voting rights breakdown

Voting rights acquired9.08%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAD5E00034

Beneficial owner

Martin und Rosmarie Ebner

Declared address

Martin und Rosmarie Ebner, 8832 Wilen

Rollover Optionen Patinex AG (wirtschaftlich Berechtigte halten Aktienmehrheit)

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Martin und Rosmarie Ebner

Vifor Pharma AG15.05.2013TAD5E00034

Disclosure summary

Martin und Rosmarie Ebner disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 15.05.2013, at 9.08% of voting rights. Notice category: Single shareholder.

Disclosed position

9.08%

Voting rights acquired

Voting rights acquired9.08%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Martin und Rosmarie Ebner disclosed a holding in Vifor Pharma AG, published on 15.05.2013.

Publication date15.05.2013

Transaction date10.05.2013

Transfer date10.05.2013

Issuing companyVifor Pharma AG

Beneficial ownerMartin und Rosmarie Ebner

Declared addressMartin und Rosmarie Ebner, 8832 Wilen

CategorySingle shareholder

Voting rights acquired9.08%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAD5E00034

Conditions

Rollover Optionen Patinex AG (wirtschaftlich Berechtigte halten Aktienmehrheit)

Source: SIX Exchange Regulation · Publication date: 15.05.2013

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open